Workflow
匠心家居(301061) - 2021 Q3 - 季度财报
MOTOMOTO(SZ:301061)2021-10-26 16:00

Financial Performance - The company's revenue for Q3 2021 reached ¥507,581,876.70, representing a year-over-year increase of 21.85%[4] - Net profit attributable to shareholders for the same period was ¥85,920,348.76, up 28.95% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥84,943,303.62, reflecting a 29.36% increase year-over-year[4] - Basic earnings per share for Q3 2021 were ¥1.43, an increase of 28.83% year-over-year[4] - The company's operating revenue for Q3 2021 reached ¥1,489,688,255.43, a 70.38% increase compared to ¥874,317,207.81 in the same period last year[9] - The net profit for the period increased to ¥638,052,943.45, reflecting a 56.68% growth from ¥407,241,213.61 year-on-year[9] - Net profit for Q3 2021 was ¥236,402,113.57, compared to ¥154,449,829.81 in Q3 2020, reflecting a growth of approximately 53.1%[31] - Earnings per share for Q3 2021 were ¥3.94, an increase from ¥2.57 in the same quarter last year, marking a rise of about 53.3%[31] - The total comprehensive income for Q3 2021 was ¥243,044,267.35, compared to ¥154,018,079.02 in the same period last year, indicating a growth of approximately 57.9%[31] Assets and Liabilities - Total assets at the end of Q3 2021 amounted to ¥3,076,918,681.64, a significant increase of 128.99% from the end of the previous year[5] - Shareholders' equity attributable to the parent company reached ¥2,443,368,455.73, marking a 186.34% increase compared to the previous year[5] - The total liabilities as of Q3 2021 amounted to ¥633,550,225.91, compared to ¥490,365,671.08 in the previous year, showing an increase of approximately 29.2%[26] - The total equity attributable to shareholders of the parent company reached ¥2,443,368,455.73, up from ¥853,308,305.14 in the same period last year, representing a growth of about 186.5%[26] - The total assets of the company were CNY 1,343,673,976.22, a decrease from CNY 1,428,480,165.59[42] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥148,280,375.02, up 25.41% year-over-year[4] - Cash inflow from operating activities increased to ¥1,639,646,087.35, up from ¥1,068,399,422.89, representing a growth of approximately 53.4%[34] - Cash inflow from financing activities amounted to ¥1,515,446,258.49, a substantial increase compared to ¥223,916,601.00 previously[36] - Net cash flow from financing activities was ¥1,363,302,372.26, compared to ¥101,560,844.48 in the prior period, reflecting a significant rise[36] - The total cash and cash equivalents at the end of the period reached ¥2,073,540,001.50, up from ¥579,888,942.23, marking an increase of approximately 258.5%[36] Expenses - Research and development expenses rose to ¥67,941,860.36, marking a 39.53% increase from ¥48,694,828.89, driven by increased investment in new product development[9] - Total operating costs for Q3 2021 were ¥1,219,450,901.51, up from ¥714,155,555.65 in the previous year, indicating an increase of about 70.6%[29] - The company reported a tax expense of ¥32,074,409.61 for Q3 2021, up from ¥12,727,691.56 in the same quarter last year, reflecting an increase of about 152.3%[29] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 24,224, indicating a broad shareholder base[12] - The company appointed Xu Meijun as the new General Manager, effective from September 28, 2021, following the resignation of the previous General Manager, Li Xiaoqin[16] Strategic Initiatives - The company plans to establish a wholly-owned subsidiary, Jiangsu Jiangxin Medical Technology Co., Ltd., in Changzhou, and another subsidiary, MotoMotion Singapore Private Limited, in Singapore to enhance brand recognition and market competitiveness[17] - The board approved the use of up to RMB 700 million of idle funds for cash management, allowing for rolling use of these funds while ensuring operational needs are met[18] - The company will utilize RMB 100 million of excess raised funds for permanent working capital supplementation, which does not exceed 30% of the total excess funds raised[21]